Enterogastrone
Overview
|
WikiDoc Resources for Enterogastrone |
|
Articles |
|---|
|
Most recent articles on Enterogastrone Most cited articles on Enterogastrone |
|
Media |
|
Powerpoint slides on Enterogastrone |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Enterogastrone at Clinical Trials.gov Trial results on Enterogastrone Clinical Trials on Enterogastrone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Enterogastrone NICE Guidance on Enterogastrone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Enterogastrone Discussion groups on Enterogastrone Patient Handouts on Enterogastrone Directions to Hospitals Treating Enterogastrone Risk calculators and risk factors for Enterogastrone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Enterogastrone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Enterogastrone is any substance in the lower gastrointestinal tract which opposes the caudal (or "forward, analward") motion of the contents of chyme when exposed to lipids.
Examples include:
References
- ↑ You C, Chey W (1987). "Secretin is an enterogastrone in humans". Dig Dis Sci. 32 (5): 466–71. PMID 2952476.
- ↑ Lloyd K, Maxwell V, Chuang C, Wong H, Soll A, Walsh J (1994). "Somatostatin is released in response to cholecystokinin by activation of type A CCK receptors". Peptides. 15 (2): 223–7. PMID 7911992.
- ↑ http://www.vivo.colostate.edu/hbooks/pathphys/endocrine/gi/gip.html
External links
- Template:EMedicineDictionary
- enterogastrone at the US National Library of Medicine Medical Subject Headings (MeSH)